Modulation of macrophage apoptosis by antimycobacterial therapy: Physiological role of apoptosis in the control of Mycobacterium tuberculosis

Toxicology and Applied Pharmacology

Volumn 190, Issue 2, 2003, Pages 111-119

  Gil, Diana ^a   Garcia, Luis F ^a   Rojas, Mauricio ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Apoptosis; Isoniazid; Monocytes macrophages; Pyrazinamide; Rifampin; Streptomycin with ethambutol

Indexed keywords

ETHAMBUTOL; INTERLEUKIN 10; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; THIOACETAZONE; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL GROWTH; BACTERIAL METABOLISM; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GRANULOMA; LUNG LAVAGE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS; TUBERCULOSIS CONTROL;

MURINAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0037484553     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00162-5     Document Type: Article

References (56)

1. Ali J. Hepatotoxic effects of tuberculosis therapy a practical approach to a tricky management problem . Postgrad. Med. 99:1996;217-220.
2. American Medical Association, 1994. Antimycobacterial drugs, in: American Medical Drugs Evaluation Annual 1995, Association (Ed.), Albany, NY, pp. 1685-1726.
3. s macrophages correlates with nitric oxide production. J. Infect. Dis. 176:1997;1552-1558.
4. Balcewicz-Sablinska, M. Katarzyna, Keane, J., Kornfeld, H., Remold, H.G., 1998. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of host TNF-R2, resulting in inactivation of TNF-alpha. J. Immunol. 161, 2636-2641.
5. Brodie M.J., Hillyard C.J. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis. J. R. Soc. Med. 75:1982;919.
6. Burnett P.K., Ameer B., Hoang K., Phifer W. Rifampicin-associated thrombocytopenia secondary to poor compliance. DICP. 23:1989;382-384.
7. Campbell E.A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., Darst S.A. Structural mechanism for rifampicin inhibition of bacterial ma polymerase. Cell. 104:2001;901-912.
8. Chan J., Tanaka K., Carrol D., Flynn J., Bloom B.R. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63:1995;736-740.
9. Collins L.A., Torrero M.N., Franzblau S.G. Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 42:1998;344-347.
10. Crowle A.J., Sbarbaro J.A., Judson F.N., Douvas G.S., May M.H. Inhibition by streptomycin of tubercle bacilli within cultured human macrophages. Am. Rev. Respir. Dis. 130:1984;839-844.
11. Fadok V.A., Savill J.S., Haslett C., Bratton D.L., Doherty D.E., Campbell P.A., Henson P.M. Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J. Immunol. 149:1992;4029-4035.
12. Filep J.G., Baron C., Lachance S., Perreault C., Chan J.S.D. Involvement of nitric oxide in target-cell lysis and dna fragmentation induced by murine natural killer cells. Blood. 87:1996;5136-5143.
13. Flynn J.L., Scanga C.A., Tanaka K.E., Chan J. Effects of aminoguanidine on latent murine tuberculosis. J. Immunol. 160:1998;1796-1803.
14. Fratazzi C., Arbeit R.D., Carini C., Remold H.G. Programmed cell death of Mycobacterium avium serovar 4-infected human macrophages prevents the mycobacteria from spreading and induces mycobacterial growth inhibition by freshly, uninfected macrophages. J. Immunol. 158:1997;4320-4327.
15. Gabai V.L., Mosina V.A., Makarova Y.M., Malyutina Y.V., Budagova K.R., Mosin A.F. Serum withdrawal induces thymocyte apoptosis not requiring protein synthesis or ATP generation. Biochem. Russia. 60:1995;907-912.
16. Gabai V.L., Zamulaeva I.V., Mosin A.F., Makarova Y.M., Mosina V.A., Budagova K.R., Malutina Y.V., Kabakov A.E. Resistance of Ehrlich tumor cells to apoptosis can be due to accumulation of heat shock proteins. FEBS Lett. 375:1995;21-26.
17. Geier A., Barshalom I., Beery R., Haimsohm M., Hemi R., Malik Z., Lunenfeld B., Karasik A. Induction of apoptosis in MDA-231 cells by protein synthesis inhibitors is suppressed by multiple agents. Cancer Invest. 14:1996;435-444.
18. Giza T., Hanicka M., Herman T., Jelonek A., Kurdzielewicz J., Rembiesowa H., Rudnik J., Wojciak W. Significance of decalcification in the treatment of tuberculosis. 8. Studies on the effect of decalcification on the course of tuberculosis caused by INH-resistant bacilli. Gruzlica. 36:1968;545-550.
19. Heng J.E., Vorwerk C.K., Lessell E., Zurakowski D., Levin L.A., Dreyer E.B. Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway. Invest. Ophthalmol. Vis. Sci. 40:1999;190-196.
20. Hopewell P.C. "The cure": organization and administration of the therapy for tuberculosis. Porter J.D.H., McAdam K.P.W.J. Tuberculosis: back to the future. 1994;99-143 J Wiley Chichester, England.
21. Jun C.D., Park S.J., Choi B.M., Kwak H.J., Park Y.C., Kim M.S., Park R.K., Chung H.T. Potentiation of the activity of nitric oxide by the protein kinase c activator phorbol ester in human myeloid leukemic HL-60 cells-association with enhanced fragmentation of mature genomic DNA. Cell. Immunol. 176:1997;41-49.
22. Klingler K., Tchou-Wong K.-M., Brandli O., Aston C., Kim R., Chi C., Rom W. Effects of myocbacteria on regulation of apoptosis in mononuclear phagocytes. Infect. Immun. 65:1997;5272-5278.
23. Koestner J.A., Jones L.K., Polk W.H., Sax P.E. Prolonged use of intravenous isoniazid and rifampin. DICP. 23:1999;48-50.
24. 2+ caused by streptomycin in the isolated cochlear OHC. Zhonghua Er Bi-Yan hou ke Zazhi. 30:1995;227-229.
25. Malik Z.A., Iyer S.S., Kusner D.J. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages . J. Immunol. 166:2001;3392-3401.
26. Marchetti P., Castedo M., Susin S.A., Zamzami N., Hirsch T., Macho A., Haeffner A., Hirsch F., Geuskens M., Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1996;1155-1160.
27. McEnroe A.S., Taber H.W. Correlation between cytochrome aa3 concentrations and streptomycin accumulation in Bacillus subtilis. Antimicrob. Agents Chemother. 26:1984;507-512.
28. 1 and CD40 in WEHI-231 cells dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction . J. Immunol. 155:1995;3830-3838.
29. Mori N., Harada Y., Kasuga S., Oda Y., Hirakawa K., Yajin K. Changes in calcium distribution in the utricular supporting cells of the guinea pig. Acta Otolaryngol. Suppl. 519:1995;71-73.
30. Nguyen T., Brunson D., Crespi C.L., Penman B.W., Wishnok J.S., Tannenbaum S.R. DNA damage and mutation of human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA. 89:1992;3030-3034.
31. Norris K.A., Schrinpf J.E., Flynn J., Morris S.M. Enhancement of macrophage microbicidal activity supplemental arginine and citrulline aument nitric oxide production in murine peritoneal macrophages and promote intracellular killing of Trypanosoma cruzi . Infect. Immun. 63:1995;2793-2796.
32. Oddo M., Renno T., Attinger A., Bakker T., MacDonald H.R., Meylan P.R.A. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J. Immunol. 10:1998;5448-5454.
33. Perry W. Calcium metabolism during rifampicin and isoniazid therapy. Tubercle. 64:1983;57-58.
34. Placido R., Mancino G., Amendola A., Mariani F., Vendetti S., Piacentini M., Sanduzzi A., Bocchino M.L., Zembala M., Colizzi V. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection. J. Pathol. 181:1997;31-38.
35. Radzioch D., Hudson T., Boule M., Barrera L., Urbance J.W., Varesio L., Skamene E. Genetic resistance/susceptibility to mycobacteria phenotypic expression in bone marrow-derived macrophage lines . J. Leukocyte. Biol. 50:1991;263.
36. Ragno S., Estrada-Garcia I., Butler R., Colston M.J. Regulation of macrophage gene expression by Mycobacterium tuberculosis: down regulation of mitochondrial cytochrome c oxidase. Infect. Immun. 66:1998;3952-3958.
37. Ravn, P., Linnet J., Klokker, M., Pedersen, B.K. 1995. Effects of isoniazid treatment on human lymphocyte proliferative response, lymphocyte subsets and natural killer cell activity. Immunopharmacol. 30, 247-253.
38. Rehen S.K., Varella M.H., Freitas F.G., Moraes M.O., Linden R. Contrasting effects of protein synthesis inhibition and of cyclic AMP on apoptosis in the developing retina. Development. 122:1996;1439-1448.
39. Richardson D.R., Hefter G.T., May P.M., Webb J., Baker E. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II). Biol. Med. 2:1989;161-167.
40. Rojas M., Barrera L.F., Garcia L.F. Induction of apoptosis in murine macrophages by Mycobacterium tuberculosis is reactive oxygen intermediates-independent. Biochem. Biophys. Res. Commun. 247:1998;436-442.
41. Rojas M., Barrera L.F., Puzo G., Garcia L.F. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages role of nitric oxide and mycobacterial products . J. Immunol. 159:1997;1352-1361.
42. +2-dependent cell signaling. J. Infect. Dis. 182:2000;240-251.
43. Rojas M., Olivier M., Gros P., Barrera L.F., Garcia L.F. TNF-alpha and IL-10 modulate the induction of apoptosis by virulent Mycobacterium tuberculosis in murine macrophages. J. Immunol. 162:1999;6122-6131.
44. Rook G.A.W., Steele J., Ainsworth M., Champion R. Activation of macrophages to inhibit proliferation of Mycobacterium tuberculosis: comparison of the effects of recombinant gamma-interferon on human monocytes and murine peritoneal macrophages. Immunology. 59:1986;333-338.
45. Rook G.A.W., Steele J., Fraher L., Barker S., Karmali R., O'Riordan J. Vitamin D3, gamma interferon and control proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 57:1986;159-163.
46. Schulz J.B., Weller M., Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species . J. Neurosci. 16:1996;4696-4706.
47. Siskind M.S., Thienemann D., Kirlin L. Isoniazid-induced neurotoxicity in chronic dialysis patoents report of three cases and a eview of literature . Nephron. 64:1999;303-306.
48. Vidal S., Tremblay M.L., Govoni G., Gauthier S., Sebastiani G., Malo D., Skamene E., Olivier M., Jothy S., Gros P. The Ity/Lsh/Bcg locus natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene . J. Exp. Med. 182:1995;655-666.
49. Wang E., Wang J., Liu S. [Experimental study of streptomycin on 45Ca intake of otolithic membranes]. Zhonghua Er-Bi-Yanlou ke Zazhi. 31:1996;280-282.
50. Wang P., Wu P., Siegel M.I., Egan R.W., Billah M.M. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J. Immunol. 153:1994;811-816.
51. Wu J.C., Peet G.W., Coutts S.J., Eckner R.J., Griffin J.A., Farina P.R. Non-sialate inhibitor of influenza A/WSN/33 neuraminidase. Biochemistry. 34:1995;7154-7160.
52. Yabuki M., Inai Y., Yoshioka T., Hamazaki K., Yasuda T., Inoue M., Utsumi K. Oxygen-dependent fragmentation of cellular DNA by nitric oxide. Free Radical Res. 26:1997;245-255.
53. Yabuki M., Kariya S., Inai Y., Hamazaki K., Yoshioka T., Yasuda T., Horton A.A., Utsumi K. Molecular mechanisms of apoptosis in HL-60 cells induced by a nitric oxide-releasing compound. Free Rad. Res. 27:1997;325-335.
54. Youmans G.P. Tuberculosis. 1979;Saunders, Philadelphia.
55. Zamzami N., Brenner C., Marzo I., Susin S.A., Kroemer G. Subcellular and submitochondrial mode of action of Bcl-2-like oncoproteimns. Oncogene. 16:1998;2265-2282.
56. Zamzami N., Marchetti P., Castedo M., Hirsch T., Susin S.A., Masse B., Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett. 384:1996;53-57.